Loading...
XSHG
600518
Market cap4.08bUSD
Jul 28, Last price  
2.12CNY
1D
-0.93%
1Q
10.42%
Jan 2017
-88.12%
IPO
85.87%
Name

Kangmei Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
P/E
285.96
P/S
6.02
EPS
0.01
Div Yield, %
—
Shrs. gr., 5y
-3.80%
Rev. gr., 5y
-22.17%
Revenues
4.87b
+16.60%
553,110,449584,613,750825,606,6161,294,056,7331,727,164,1512,377,160,9013,308,801,6406,080,507,22511,165,154,81813,358,728,51715,949,188,76918,066,827,95221,642,324,07017,578,618,64017,065,079,13911,445,545,8105,412,007,9614,152,521,0994,180,150,3294,874,016,143
Net income
103m
71,210,12572,646,31399,889,496146,109,126294,575,387501,508,534715,522,7121,005,031,0181,441,191,4881,879,816,9942,285,879,1212,756,734,5983,340,403,6404,100,926,148374,492,320007,917,900,6230102,521,231
CFO
-318m
78,522,066133,131,86368,318,922162,553,1073,015,266119,466,024669,185,655574,964,0931,008,350,2051,674,010,6281,132,203,880508,863,2251,603,189,3511,842,794,237305,616,7272,882,044,9861,031,392,101214,205,1020-317,521,754
Dividend
Aug 28, 20190.024 CNY/sh

Profile

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese medicines in China. It also offers chemical drug products; and operates hospitals and Chinese medicine pharmacies. The company was founded in 1997 and is headquartered in Puning, China.
URL
http://www.kangmei.com.cn/
IPO date
Mar 19, 2001
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,874,016
16.60%
4,180,150
0.67%
Cost of revenue
5,056,352
4,223,335
Unusual Expense (Income)
NOPBT
(182,336)
(43,185)
NOPBT Margin
Operating Taxes
6,800
30,270
Tax Rate
NOPAT
(189,135)
(73,454)
Net income
102,521
 
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
26,137
64,736
Long-term debt
376,326
398,261
Deferred revenue
618,683
653,982
Other long-term liabilities
1,661,378
1,834,587
Net debt
(655,379)
(1,045,792)
Cash flow
Cash from operating activities
(317,522)
CAPEX
(99,745)
Cash from investing activities
(37,642)
Cash from financing activities
FCF
(1,054,686)
859,680
Balance
Cash
1,056,689
1,507,515
Long term investments
1,152
1,274
Excess cash
814,141
1,299,781
Stockholders' equity
(10,477,421)
14,239,068
Invested Capital
20,052,233
7,436,657
ROIC
ROCE
EV
Common stock shares outstanding
10,252,123
13,863,867
Price
1.86
-15.45%
2.20
-28.80%
Market cap
19,068,949
-37.48%
30,500,507
-28.80%
EV
18,446,462
29,490,133
EBITDA
163,840
322,505
EV/EBITDA
112.59
91.44
Interest
56,154
78,897
Interest/NOPBT